---
schema_version: "secwatch.filing_event.v1"
accession: "0001193125-24-255170"
form_type: "8-K"
ticker: "HOWL"
cik: "0001785530"
company_name: "Werewolf Therapeutics, Inc."
filed_at: "2024-11-12T23:59:59+00:00"
generated_at: "2026-05-30T02:05:40.024305+00:00"
event_type: "other"
sentiment: "neutral"
materiality_score: 0.05
calibrated_materiality_score: 0.05
confidence: "low"
source: SEC EDGAR
---

# Werewolf Therapeutics posts updated corporate presentation with no disclosed material changes

## Summary
- Company made an updated corporate presentation available on its website on November 12, 2024.
- Presentation furnished as Exhibit 99.1; no specific financial or operational updates detailed in the filing.
- No new financial guidance, clinical data, or corporate developments disclosed in the 8-K.

## SEC filing metadata
- accession: 0001193125-24-255170
- form_type: 8-K
- ticker: HOWL
- cik: 0001785530
- company_name: Werewolf Therapeutics, Inc.
- filed_at: 2024-11-12T23:59:59+00:00
- event_type: other
- sentiment: neutral
- materiality_score: 0.05
- calibrated_materiality_score: 0.05
- confidence: low
- sec_items: 7.01, 9.01
- EDGAR index: https://www.sec.gov/Archives/edgar/data/1785530/000119312524255170/0001193125-24-255170-index.htm
- EDGAR primary document: https://www.sec.gov/Archives/edgar/data/1785530/000119312524255170/d794017d8k.htm

## Machine-readable alternates
- HTML: https://secwatch.observer/filing/0001193125-24-255170
- JSON: https://secwatch.observer/filing/0001193125-24-255170.json
- Plain text: https://secwatch.observer/filing/0001193125-24-255170.txt

This AI-assisted summary is a reading aid. Review the linked SEC EDGAR filing before relying on any specific claim.